TIMP1 and non-small cell lung carcinoma: To unequivocally demonstrate the contributions of TIMP-1 and IL-6 to chemoresistance, we generated chemoresistant clones of NSCLC cells by a continuous escalation of drug dose over a span of three months (Supplementary Figure S5B).